位置:首页 > 蛋白库 > GHR1_ARATH
GHR1_ARATH
ID   GHR1_ARATH              Reviewed;        1053 AA.
AC   C0LGQ9; F4JIJ5; Q9SUB9; T1T4Z8;
DT   03-NOV-2009, integrated into UniProtKB/Swiss-Prot.
DT   13-FEB-2019, sequence version 2.
DT   03-AUG-2022, entry version 93.
DE   RecName: Full=LRR receptor-like serine/threonine-protein kinase GHR1 {ECO:0000303|PubMed:22730405};
DE            EC=2.7.11.1 {ECO:0000269|PubMed:22730405};
DE   AltName: Full=Protein GUARD CELL HYDROGEN PEROXIDE-RESISTANT 1 {ECO:0000303|PubMed:22730405};
DE            Short=AtGHR1 {ECO:0000303|PubMed:22730405};
DE   AltName: Full=Protein RADICAL-INDUCED CELL DEATH 7 {ECO:0000303|PubMed:30361234};
DE   Flags: Precursor;
GN   Name=GHR1 {ECO:0000303|PubMed:22730405};
GN   Synonyms=RCD7 {ECO:0000303|PubMed:30361234};
GN   OrderedLocusNames=At4g20940 {ECO:0000312|Araport:AT4G20940};
GN   ORFNames=T13K14.100 {ECO:0000312|EMBL:CAB45889.1};
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae;
OC   rosids; malvids; Brassicales; Brassicaceae; Camelineae; Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, DISRUPTION PHENOTYPE, MUTAGENESIS OF
RP   CYS-57; CYS-66; CYS-381 AND LYS-798, CATALYTIC ACTIVITY, TISSUE
RP   SPECIFICITY, INTERACTION WITH SLAC1 AND ABI2, SUBCELLULAR LOCATION, AND
RP   ACTIVITY REGULATION.
RC   STRAIN=cv. Columbia;
RX   PubMed=22730405; DOI=10.1105/tpc.112.100107;
RA   Hua D., Wang C., He J., Liao H., Duan Y., Zhu Z., Guo Y., Chen Z., Gong Z.;
RT   "A plasma membrane receptor kinase, GHR1, mediates abscisic acid- and
RT   hydrogen peroxide-regulated stomatal movement in Arabidopsis.";
RL   Plant Cell 24:2546-2561(2012).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=10617198; DOI=10.1038/47134;
RA   Mayer K.F.X., Schueller C., Wambutt R., Murphy G., Volckaert G., Pohl T.,
RA   Duesterhoeft A., Stiekema W., Entian K.-D., Terryn N., Harris B.,
RA   Ansorge W., Brandt P., Grivell L.A., Rieger M., Weichselgartner M.,
RA   de Simone V., Obermaier B., Mache R., Mueller M., Kreis M., Delseny M.,
RA   Puigdomenech P., Watson M., Schmidtheini T., Reichert B., Portetelle D.,
RA   Perez-Alonso M., Boutry M., Bancroft I., Vos P., Hoheisel J.,
RA   Zimmermann W., Wedler H., Ridley P., Langham S.-A., McCullagh B.,
RA   Bilham L., Robben J., van der Schueren J., Grymonprez B., Chuang Y.-J.,
RA   Vandenbussche F., Braeken M., Weltjens I., Voet M., Bastiaens I., Aert R.,
RA   Defoor E., Weitzenegger T., Bothe G., Ramsperger U., Hilbert H., Braun M.,
RA   Holzer E., Brandt A., Peters S., van Staveren M., Dirkse W., Mooijman P.,
RA   Klein Lankhorst R., Rose M., Hauf J., Koetter P., Berneiser S., Hempel S.,
RA   Feldpausch M., Lamberth S., Van den Daele H., De Keyser A., Buysshaert C.,
RA   Gielen J., Villarroel R., De Clercq R., van Montagu M., Rogers J.,
RA   Cronin A., Quail M.A., Bray-Allen S., Clark L., Doggett J., Hall S.,
RA   Kay M., Lennard N., McLay K., Mayes R., Pettett A., Rajandream M.A.,
RA   Lyne M., Benes V., Rechmann S., Borkova D., Bloecker H., Scharfe M.,
RA   Grimm M., Loehnert T.-H., Dose S., de Haan M., Maarse A.C., Schaefer M.,
RA   Mueller-Auer S., Gabel C., Fuchs M., Fartmann B., Granderath K., Dauner D.,
RA   Herzl A., Neumann S., Argiriou A., Vitale D., Liguori R., Piravandi E.,
RA   Massenet O., Quigley F., Clabauld G., Muendlein A., Felber R., Schnabl S.,
RA   Hiller R., Schmidt W., Lecharny A., Aubourg S., Chefdor F., Cooke R.,
RA   Berger C., Monfort A., Casacuberta E., Gibbons T., Weber N., Vandenbol M.,
RA   Bargues M., Terol J., Torres A., Perez-Perez A., Purnelle B., Bent E.,
RA   Johnson S., Tacon D., Jesse T., Heijnen L., Schwarz S., Scholler P.,
RA   Heber S., Francs P., Bielke C., Frishman D., Haase D., Lemcke K.,
RA   Mewes H.-W., Stocker S., Zaccaria P., Bevan M., Wilson R.K.,
RA   de la Bastide M., Habermann K., Parnell L., Dedhia N., Gnoj L., Schutz K.,
RA   Huang E., Spiegel L., Sekhon M., Murray J., Sheet P., Cordes M.,
RA   Abu-Threideh J., Stoneking T., Kalicki J., Graves T., Harmon G.,
RA   Edwards J., Latreille P., Courtney L., Cloud J., Abbott A., Scott K.,
RA   Johnson D., Minx P., Bentley D., Fulton B., Miller N., Greco T., Kemp K.,
RA   Kramer J., Fulton L., Mardis E., Dante M., Pepin K., Hillier L.W.,
RA   Nelson J., Spieth J., Ryan E., Andrews S., Geisel C., Layman D., Du H.,
RA   Ali J., Berghoff A., Jones K., Drone K., Cotton M., Joshu C., Antonoiu B.,
RA   Zidanic M., Strong C., Sun H., Lamar B., Yordan C., Ma P., Zhong J.,
RA   Preston R., Vil D., Shekher M., Matero A., Shah R., Swaby I.K.,
RA   O'Shaughnessy A., Rodriguez M., Hoffman J., Till S., Granat S., Shohdy N.,
RA   Hasegawa A., Hameed A., Lodhi M., Johnson A., Chen E., Marra M.A.,
RA   Martienssen R., McCombie W.R.;
RT   "Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana.";
RL   Nature 402:769-777(1999).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RX   PubMed=27862469; DOI=10.1111/tpj.13415;
RA   Cheng C.Y., Krishnakumar V., Chan A.P., Thibaud-Nissen F., Schobel S.,
RA   Town C.D.;
RT   "Araport11: a complete reannotation of the Arabidopsis thaliana reference
RT   genome.";
RL   Plant J. 89:789-804(2017).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 17-1053.
RC   STRAIN=cv. Columbia;
RX   PubMed=20064227; DOI=10.1186/1471-2164-11-19;
RA   Gou X., He K., Yang H., Yuan T., Lin H., Clouse S.D., Li J.;
RT   "Genome-wide cloning and sequence analysis of leucine-rich repeat receptor-
RT   like protein kinase genes in Arabidopsis thaliana.";
RL   BMC Genomics 11:19-19(2010).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-704, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19376835; DOI=10.1104/pp.109.138677;
RA   Reiland S., Messerli G., Baerenfaller K., Gerrits B., Endler A.,
RA   Grossmann J., Gruissem W., Baginsky S.;
RT   "Large-scale Arabidopsis phosphoproteome profiling reveals novel
RT   chloroplast kinase substrates and phosphorylation networks.";
RL   Plant Physiol. 150:889-903(2009).
RN   [6]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND PHOSPHORYLATION.
RC   STRAIN=cv. Columbia;
RX   PubMed=27694184; DOI=10.1105/tpc.16.00131;
RA   Horak H., Sierla M., Toldsepp K., Wang C., Wang Y.-S., Nuhkat M., Valk E.,
RA   Pechter P., Merilo E., Salojaervi J., Overmyer K., Loog M., Brosche M.,
RA   Schroeder J.I., Kangasjaervi J., Kollist H.;
RT   "A dominant mutation in the HT1 kinase uncovers roles of MAP kinases and
RT   GHR1 in CO2-induced stomatal closure.";
RL   Plant Cell 28:2493-2509(2016).
RN   [7]
RP   FUNCTION, DISRUPTION PHENOTYPE, MUTAGENESIS OF GLY-56; GLY-63; GLY-108;
RP   ASP-220; ASP-293; ALA-618; ALA-637; SER-680 AND LYS-798, INTERACTION WITH
RP   CPK3 AND SLAC1, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND
RP   PHOSPHORYLATION AT SER-100; SER-102; SER-105; SER-126; SER-262; SER-278;
RP   THR-280; SER-281; SER-325; TYR-406; SER-410; THR-415; SER-417; SER-434;
RP   SER-613; SER-614; SER-616; THR-669; THR-675; SER-678; SER-680; SER-698;
RP   SER-699; SER-700; THR-713; SER-716; SER-718; THR-720; SER-721; SER-724;
RP   SER-760; THR-764; SER-769; THR-928; THR-1010; SER-1015; THR-1045; TYR-1047;
RP   SER-1051 AND SER-1052.
RC   STRAIN=cv. Columbia, and cv. Columbia GL1;
RX   PubMed=30361234; DOI=10.1105/tpc.18.00441;
RA   Sierla M., Horak H., Overmyer K., Waszczak C., Yarmolinsky D.,
RA   Maierhofer T., Vainonen J.P., Denessiouk K., Salojaervi J., Laanemets K.,
RA   Toldsepp K., Vahisalu T., Gauthier A., Puukko T., Paulin L., Auvinen P.,
RA   Geiger D., Hedrich R., Kollist H., Kangasjaervi J.;
RT   "The receptor-like pseudokinase GHR1 is required for stomatal closure.";
RL   Plant Cell 30:2813-2837(2018).
RN   [8]
RP   FUNCTION.
RX   PubMed=29463779; DOI=10.1126/scisignal.aam9514;
RA   Devireddy A.R., Zandalinas S.I., Gomez-Cadenas A., Blumwald E., Mittler R.;
RT   "Coordinating the overall stomatal response of plants: Rapid leaf-to-leaf
RT   communication during light stress.";
RL   Sci. Signal. 11:0-0(2018).
CC   -!- FUNCTION: Receptor kinase acting as an early component in abscisic acid
CC       (ABA) signaling (PubMed:22730405). Required for darkness, ABA, high
CC       CO(2) and hydrogen peroxide (H(2)O(2)) induction of S-type anion
CC       currents in guard cells leading to stomatal closure, possibly via the
CC       phosphorylation and activation of the anion channel SLAC1 and as a
CC       scaffolding component (PubMed:22730405, PubMed:27694184,
CC       PubMed:30361234). Seems to act in parallel with SRK2E/OST1 in the ABA
CC       signaling pathway which regulates stomatal movement (PubMed:22730405).
CC       Binds ATP (PubMed:30361234). Involved in the local and/or systemic
CC       stomatal responses (e.g. stomatal closure) to light stress
CC       (PubMed:29463779). {ECO:0000269|PubMed:22730405,
CC       ECO:0000269|PubMed:27694184, ECO:0000269|PubMed:29463779,
CC       ECO:0000269|PubMed:30361234}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000269|PubMed:22730405};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000269|PubMed:22730405};
CC   -!- ACTIVITY REGULATION: Negatively regulated by ABI2.
CC       {ECO:0000269|PubMed:22730405}.
CC   -!- SUBUNIT: Interacts with SLAC1 (via N-terminus) (PubMed:22730405,
CC       PubMed:30361234). Binds to ABI2, but not ABI1 (PubMed:22730405).
CC       Interacts with CPK3 (PubMed:30361234). {ECO:0000269|PubMed:22730405,
CC       ECO:0000269|PubMed:30361234}.
CC   -!- INTERACTION:
CC       C0LGQ9; C0LGL4: At2g28960; NbExp=2; IntAct=EBI-16939160, EBI-16946048;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:22730405,
CC       ECO:0000269|PubMed:30361234}; Single-pass type I membrane protein
CC       {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Expressed in guard cells and in the vasculature of
CC       roots and leaves. {ECO:0000269|PubMed:22730405,
CC       ECO:0000269|PubMed:30361234}.
CC   -!- DOMAIN: The protein kinase domain is predicted to be catalytically
CC       inactive. {ECO:0000255|PROSITE-ProRule:PRU00159,
CC       ECO:0000303|PubMed:30361234}.
CC   -!- PTM: Phosphorylated by HT1; this phosphorylation is inhibited by MPK12
CC       and MPK4. {ECO:0000269|PubMed:27694184, ECO:0000269|PubMed:30361234}.
CC   -!- DISRUPTION PHENOTYPE: No visible phenotype under normal growth
CC       conditions but early wilting (PubMed:22730405). Increased sensitivity
CC       to drought stress due to impaired stomatal closure and increased water
CC       loss (PubMed:22730405). Abolished CO(2)-mediated and darkness-induced
CC       stomatal closure (PubMed:27694184). Defective abscisic acid (ABA) and
CC       hydrogen peroxide (H(2)O(2)) induction of stomatal closure associated
CC       with an impaired activation of S-type anion currents in guard cells
CC       (PubMed:22730405). Impaired stomatal closure after treatment with
CC       methyl jasmonate (MeJA), salicylic acid (SA) and flagellin 22 (Flg22)
CC       (PubMed:29463779). Altered ABA-mediated inhibition of light-induced
CC       stomatal opening (PubMed:22730405). Apoplastic ROS-sensitive plants
CC       exhibiting severe tissue damage when exposed to ozone (O3)
CC       (PubMed:30361234). {ECO:0000269|PubMed:22730405,
CC       ECO:0000269|PubMed:27694184, ECO:0000269|PubMed:29463779,
CC       ECO:0000269|PubMed:30361234}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr protein
CC       kinase family. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   -!- CAUTION: Exhibits protein kinase activity according to PubMed:22730405,
CC       but in contradiction, described as an inactive pseudokinase by
CC       PubMed:30361234. {ECO:0000305|PubMed:22730405,
CC       ECO:0000305|PubMed:30361234}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AEE84378.2; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAB45889.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAB79094.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; KF531634; AGT59499.1; -; mRNA.
DR   EMBL; AL080282; CAB45889.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL161554; CAB79094.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CP002687; AEE84378.2; ALT_INIT; Genomic_DNA.
DR   EMBL; FJ708750; ACN59344.1; -; mRNA.
DR   PIR; T10636; T10636.
DR   RefSeq; NP_001320016.1; NM_001341467.1.
DR   AlphaFoldDB; C0LGQ9; -.
DR   SMR; C0LGQ9; -.
DR   BioGRID; 13133; 47.
DR   IntAct; C0LGQ9; 48.
DR   STRING; 3702.AT4G20940.1; -.
DR   TCDB; 1.A.87.2.4; the mechanosensitive calcium channel (mca) family.
DR   iPTMnet; C0LGQ9; -.
DR   PaxDb; C0LGQ9; -.
DR   PRIDE; C0LGQ9; -.
DR   ProteomicsDB; 242849; -.
DR   EnsemblPlants; AT4G20940.1; AT4G20940.1; AT4G20940.
DR   GeneID; 827842; -.
DR   Gramene; AT4G20940.1; AT4G20940.1; AT4G20940.
DR   KEGG; ath:AT4G20940; -.
DR   Araport; AT4G20940; -.
DR   eggNOG; ENOG502QUKN; Eukaryota.
DR   InParanoid; C0LGQ9; -.
DR   OrthoDB; 826997at2759; -.
DR   PhylomeDB; C0LGQ9; -.
DR   PRO; PR:C0LGQ9; -.
DR   Proteomes; UP000006548; Chromosome 4.
DR   ExpressionAtlas; C0LGQ9; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0009738; P:abscisic acid-activated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0071485; P:cellular response to absence of light; IMP:UniProtKB.
DR   GO; GO:0071244; P:cellular response to carbon dioxide; IMP:UniProtKB.
DR   GO; GO:1901528; P:hydrogen peroxide mediated signaling pathway involved in stomatal movement; IMP:UniProtKB.
DR   GO; GO:0009789; P:positive regulation of abscisic acid-activated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IEA:InterPro.
DR   GO; GO:0090333; P:regulation of stomatal closure; IMP:UniProtKB.
DR   GO; GO:0009737; P:response to abscisic acid; IMP:UniProtKB.
DR   GO; GO:0009416; P:response to light stimulus; IMP:UniProtKB.
DR   Gene3D; 3.80.10.10; -; 2.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR013210; LRR_N_plant-typ.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   Pfam; PF13516; LRR_6; 2.
DR   Pfam; PF13855; LRR_8; 3.
DR   Pfam; PF08263; LRRNT_2; 1.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   SMART; SM00369; LRR_TYP; 8.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   Abscisic acid signaling pathway; ATP-binding; Cell membrane; Glycoprotein;
KW   Kinase; Leucine-rich repeat; Membrane; Nucleotide-binding; Phosphoprotein;
KW   Receptor; Reference proteome; Repeat; Serine/threonine-protein kinase;
KW   Signal; Stress response; Transferase; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000255"
FT   CHAIN           19..1053
FT                   /note="LRR receptor-like serine/threonine-protein kinase
FT                   GHR1"
FT                   /id="PRO_0000387555"
FT   TOPO_DOM        19..630
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        631..651
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        652..1053
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   REPEAT          73..93
FT                   /note="LRR 1"
FT                   /evidence="ECO:0000255"
FT   REPEAT          94..119
FT                   /note="LRR 2"
FT                   /evidence="ECO:0000255"
FT   REPEAT          121..141
FT                   /note="LRR 3"
FT                   /evidence="ECO:0000255"
FT   REPEAT          142..165
FT                   /note="LRR 4"
FT                   /evidence="ECO:0000255"
FT   REPEAT          166..189
FT                   /note="LRR 5"
FT                   /evidence="ECO:0000255"
FT   REPEAT          191..212
FT                   /note="LRR 6"
FT                   /evidence="ECO:0000255"
FT   REPEAT          213..237
FT                   /note="LRR 7"
FT                   /evidence="ECO:0000255"
FT   REPEAT          239..260
FT                   /note="LRR 8"
FT                   /evidence="ECO:0000255"
FT   REPEAT          262..285
FT                   /note="LRR 9"
FT                   /evidence="ECO:0000255"
FT   REPEAT          286..309
FT                   /note="LRR 10"
FT                   /evidence="ECO:0000255"
FT   REPEAT          310..333
FT                   /note="LRR 11"
FT                   /evidence="ECO:0000255"
FT   REPEAT          335..357
FT                   /note="LRR 12"
FT                   /evidence="ECO:0000255"
FT   REPEAT          358..384
FT                   /note="LRR 13"
FT                   /evidence="ECO:0000255"
FT   REPEAT          401..425
FT                   /note="LRR 14"
FT                   /evidence="ECO:0000255"
FT   REPEAT          426..449
FT                   /note="LRR 15"
FT                   /evidence="ECO:0000255"
FT   REPEAT          450..474
FT                   /note="LRR 16"
FT                   /evidence="ECO:0000255"
FT   REPEAT          476..498
FT                   /note="LRR 17"
FT                   /evidence="ECO:0000255"
FT   REPEAT          499..521
FT                   /note="LRR 18"
FT                   /evidence="ECO:0000255"
FT   REPEAT          522..546
FT                   /note="LRR 19"
FT                   /evidence="ECO:0000255"
FT   REPEAT          548..570
FT                   /note="LRR 20"
FT                   /evidence="ECO:0000255"
FT   REPEAT          572..592
FT                   /note="LRR 21"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          770..1053
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          662..684
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         776..784
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         798
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         100
FT                   /note="Phosphoserine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         102
FT                   /note="Phosphoserine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         105
FT                   /note="Phosphoserine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         126
FT                   /note="Phosphoserine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         262
FT                   /note="Phosphoserine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         278
FT                   /note="Phosphoserine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         280
FT                   /note="Phosphothreonine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         281
FT                   /note="Phosphoserine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         325
FT                   /note="Phosphoserine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         406
FT                   /note="Phosphotyrosine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         410
FT                   /note="Phosphoserine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         415
FT                   /note="Phosphothreonine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         417
FT                   /note="Phosphoserine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         434
FT                   /note="Phosphoserine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         613
FT                   /note="Phosphoserine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         614
FT                   /note="Phosphoserine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         616
FT                   /note="Phosphoserine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         669
FT                   /note="Phosphothreonine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         675
FT                   /note="Phosphothreonine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         678
FT                   /note="Phosphoserine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         680
FT                   /note="Phosphoserine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         698
FT                   /note="Phosphoserine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         699
FT                   /note="Phosphoserine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         700
FT                   /note="Phosphoserine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         704
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:19376835"
FT   MOD_RES         713
FT                   /note="Phosphothreonine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         716
FT                   /note="Phosphoserine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         718
FT                   /note="Phosphoserine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         720
FT                   /note="Phosphothreonine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         721
FT                   /note="Phosphoserine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         724
FT                   /note="Phosphoserine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         760
FT                   /note="Phosphoserine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         764
FT                   /note="Phosphothreonine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         769
FT                   /note="Phosphoserine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         928
FT                   /note="Phosphothreonine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         1010
FT                   /note="Phosphothreonine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         1015
FT                   /note="Phosphoserine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         1045
FT                   /note="Phosphothreonine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         1047
FT                   /note="Phosphotyrosine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         1051
FT                   /note="Phosphoserine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MOD_RES         1052
FT                   /note="Phosphoserine; by HT1"
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   CARBOHYD        92
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        103
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        146
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        153
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        196
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        239
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        269
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        347
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        394
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        432
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        534
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        566
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        575
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        621
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   MUTAGEN         56
FT                   /note="G->D: In ghr1-13; apoplastic ROS-sensitive plants
FT                   exhibiting increased tissue damage when exposed to ozone
FT                   (O3) and slightly higher steady-state stomatal conductance;
FT                   when associated with N-220."
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MUTAGEN         57
FT                   /note="C->A: Abolishes the capacity to complement the water
FT                   loss phenotype of the ghr1 mutant."
FT                   /evidence="ECO:0000269|PubMed:22730405"
FT   MUTAGEN         63
FT                   /note="G->D: In ghr1-12; apoplastic ROS-sensitive plants
FT                   exhibiting increased tissue damage when exposed to ozone
FT                   (O3). Slightly higher steady-state stomatal conductance."
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MUTAGEN         66
FT                   /note="C->A: Abolishes the capacity to complement the water
FT                   loss phenotype of the ghr1 mutant."
FT                   /evidence="ECO:0000269|PubMed:22730405"
FT   MUTAGEN         108
FT                   /note="G->D: In ghr1-7; apoplastic ROS-sensitive plants
FT                   exhibiting increased tissue damage when exposed to ozone
FT                   (O3). Slightly higher steady-state stomatal conductance."
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MUTAGEN         220
FT                   /note="D->N: In ghr1-13; apoplastic ROS-sensitive plants
FT                   exhibiting increased tissue damage when exposed to ozone
FT                   (O3) and slightly higher steady-state stomatal conductance;
FT                   when associated with D-56."
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MUTAGEN         293
FT                   /note="D->N: In ghr1-8; apoplastic ROS-sensitive plants
FT                   exhibiting increased tissue damage when exposed to ozone
FT                   (O3). Slightly higher steady-state stomatal conductance."
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MUTAGEN         381
FT                   /note="C->A: No effect on the capacity to complement the
FT                   water loss phenotype of the ghr1 mutant."
FT                   /evidence="ECO:0000269|PubMed:22730405"
FT   MUTAGEN         618
FT                   /note="A->T: In ghr1-2/rcd7 and ghr1-10; apoplastic ROS-
FT                   sensitive plants exhibiting increased tissue damage when
FT                   exposed to ozone (O3). Slightly higher steady-state
FT                   stomatal conductance."
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MUTAGEN         637
FT                   /note="A->V: In ghr1-15; apoplastic ROS-sensitive plants
FT                   exhibiting increased tissue damage when exposed to ozone
FT                   (O3). Slightly higher steady-state stomatal conductance."
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MUTAGEN         680
FT                   /note="S->N: In ghr1-16; apoplastic ROS-sensitive plants
FT                   exhibiting increased tissue damage when exposed to ozone
FT                   (O3). Slightly higher steady-state stomatal conductance."
FT                   /evidence="ECO:0000269|PubMed:30361234"
FT   MUTAGEN         798
FT                   /note="K->E: Loss of phosphorylation activity on SLAC1."
FT                   /evidence="ECO:0000269|PubMed:22730405"
FT   MUTAGEN         798
FT                   /note="K->W: Impaired ATP binding."
FT                   /evidence="ECO:0000269|PubMed:22730405"
SQ   SEQUENCE   1053 AA;  113881 MW;  9A714A3EC89C02AB CRC64;
     MNLSRILLLS MFFLSAMGQL PSQDIMALLE FKKGIKHDPT GFVLNSWNDE SIDFNGCPSS
     WNGIVCNGGN VAGVVLDNLG LTADADFSLF SNLTKLVKLS MSNNSLSGVL PNDLGSFKSL
     QFLDLSDNLF SSSLPKEIGR SVSLRNLSLS GNNFSGEIPE SMGGLISLQS LDMSSNSLSG
     PLPKSLTRLN DLLYLNLSSN GFTGKMPRGF ELISSLEVLD LHGNSIDGNL DGEFFLLTNA
     SYVDISGNRL VTTSGKLLPG VSESIKHLNL SHNQLEGSLT SGFQLFQNLK VLDLSYNMLS
     GELPGFNYVY DLEVLKLSNN RFSGSLPNNL LKGDSLLLTT LDLSGNNLSG PVSSIMSTTL
     HTLDLSSNSL TGELPLLTGG CVLLDLSNNQ FEGNLTRWSK WENIEYLDLS QNHFTGSFPD
     ATPQLLRANH LNLSYNKLTG SLPERIPTHY PKLRVLDISS NSLEGPIPGA LLSMPTLEEI
     HLQNNGMTGN IGPLPSSGSR IRLLDLSHNR FDGDLPGVFG SLTNLQVLNL AANNLSGSLP
     SSMNDIVSLS SLDVSQNHFT GPLPSNLSSN IMAFNVSYND LSGTVPENLK NFPPPSFYPG
     NSKLVLPAGS PGSSASEASK NKSTNKLVKV VIIVSCAVAL IILILVAILL FCICKSRRRE
     ERSITGKETN RRAQTIPSGS GGGMVVSAED LVASRKGSSS EILSPDEKLA VATGFSPSKT
     SNLSWSPGSG DSFPADQQLA RLDVRSPDRL VGELHFLDDS IKLTPEELSR APAEVLGRSS
     HGTSYRATLD NGVFLTVKWL REGVAKQRKE FAKEVKKFSN IRHPNVVTLR GYYWGPTQHE
     KLILSDYISP GSLASFLYDR PGRKGPPLAW TQRLKIAVDV ARGLNYLHFD RAVPHGNLKA
     TNILLDGAEL NARVADYCLH RLMTQAGTVE QILDAGILGY RAPELAASRK PLPSFKSDVY
     AFGVILLEIL TGRCAGDVIT GEQEGVDLTD WVRLRVAEGR GAECFDSVLT QEMGSDPVTE
     KGMKEVLGIA LRCIRSVSER PGIKTIYEDL SSI
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024